Comparison of Vasodilator Response of Inhaled Epoprostenol and Inhaled Nitric Oxide

NCT04231084 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

115

Enrollment

OTHER

Sponsor class

Conditions

Pulmonary Hypertension

Interventions

DRUG: Vasodilator testing (Inhaled Nitric Oxide)
DRUG: Vasodilator testing (Inhaled Epoprostenol)

Sponsor

Brigham and Women's Hospital